Dane Saglio
Director of Finance/CFO at BULLFROG AI HOLDINGS, INC.
Net worth: 165 140 $ as of 30/05/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Vininder Singh | M | 55 | 7 years | |
| Jason Hanson | M | 55 | 1 years | |
| R. Elsey | M | 71 | 1 years | |
| William Enright | M | 61 | 1 years | |
| Kristin Bigos | M | - | - | |
| David Recker | M | 66 | - | |
| Billl Hirschman | M | - | - | |
| JT Koffenberger | M | - | - | |
| Toby Sayre | M | - | 1 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| C. Neil Lyons | M | 66 | 6 years | |
| Cary Claiborne | M | 64 |
New Generation Biofuels Holdings, Inc.
 New Generation Biofuels Holdings, Inc. Chemicals: SpecialtyProcess Industries New Generation Biofuels Holdings, Inc. is a clean energy company which deploys novel technologies to produce cleaner, renewable biofuels. The company offers its biofuels for use in diesel fuel applications, including power generation, commercial and industrial heating, and marine transportation. It produces the biofuels using a blending technology. The firm operates through its wholly owned subsidiary, New Generation Biofuels, Inc., which holds an exclusive license for North America, Central America and the Caribbean to commercialize proprietary emulsion technology. The company was founded in February 2006 and is headquartered in Columbia, MD. | 4 years |
| John W. Holaday | M | 78 |
CASI Pharmaceuticals, Inc. /Old/
 CASI Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology CASI Pharmaceuticals, Inc. is a biopharmaceutical company, which is focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs. The company develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong, and Macau. Its products include Zevalin, Evomela, and Marqibo. The company was founded in 1991 and is headquartered in Rockville, MD. | 12 years |
| Kenneth Carter | M | 65 | 2 years | |
| Cynthia Hu | M | 54 |
CASI Pharmaceuticals, Inc. /Old/
CASI Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology CASI Pharmaceuticals, Inc. is a biopharmaceutical company, which is focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs. The company develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong, and Macau. Its products include Zevalin, Evomela, and Marqibo. The company was founded in 1991 and is headquartered in Rockville, MD. | - |
| Neil Campbell | M | 64 |
Helomics Corp.
 Helomics Corp. Medical/Nursing ServicesHealth Services Helomics Corp. provides cancer care development and treatment consulting services. Its products include chemoFx, biospeciFx, geneFx colon and geneFx lung. It also offers research and development services. The company was founded in 1995 and is headquartered in Pittsburgh, PA. | 2 years |
| Sean McDonald | M | 63 |
Helomics Corp.
Helomics Corp. Medical/Nursing ServicesHealth Services Helomics Corp. provides cancer care development and treatment consulting services. Its products include chemoFx, biospeciFx, geneFx colon and geneFx lung. It also offers research and development services. The company was founded in 1995 and is headquartered in Pittsburgh, PA. | 13 years |
| Jim Burns | M | 77 |
CASI Pharmaceuticals, Inc. /Old/
CASI Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology CASI Pharmaceuticals, Inc. is a biopharmaceutical company, which is focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs. The company develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong, and Macau. Its products include Zevalin, Evomela, and Marqibo. The company was founded in 1991 and is headquartered in Rockville, MD. | 4 years |
| Dwight Bush | M | 67 |
CASI Pharmaceuticals, Inc. /Old/
CASI Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology CASI Pharmaceuticals, Inc. is a biopharmaceutical company, which is focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs. The company develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong, and Macau. Its products include Zevalin, Evomela, and Marqibo. The company was founded in 1991 and is headquartered in Rockville, MD. | 10 years |
| L. Thompson Bowles | M | 92 | 8 years | |
| Matthew Kalnik | M | 61 | 1 years | |
| Andrea Festuccia | M | 51 |
New Generation Biofuels Holdings, Inc.
New Generation Biofuels Holdings, Inc. Chemicals: SpecialtyProcess Industries New Generation Biofuels Holdings, Inc. is a clean energy company which deploys novel technologies to produce cleaner, renewable biofuels. The company offers its biofuels for use in diesel fuel applications, including power generation, commercial and industrial heating, and marine transportation. It produces the biofuels using a blending technology. The firm operates through its wholly owned subsidiary, New Generation Biofuels, Inc., which holds an exclusive license for North America, Central America and the Caribbean to commercialize proprietary emulsion technology. The company was founded in February 2006 and is headquartered in Columbia, MD. | 5 years |
| Miles F. Mahoney | M | 56 |
New Generation Biofuels Holdings, Inc.
New Generation Biofuels Holdings, Inc. Chemicals: SpecialtyProcess Industries New Generation Biofuels Holdings, Inc. is a clean energy company which deploys novel technologies to produce cleaner, renewable biofuels. The company offers its biofuels for use in diesel fuel applications, including power generation, commercial and industrial heating, and marine transportation. It produces the biofuels using a blending technology. The firm operates through its wholly owned subsidiary, New Generation Biofuels, Inc., which holds an exclusive license for North America, Central America and the Caribbean to commercialize proprietary emulsion technology. The company was founded in February 2006 and is headquartered in Columbia, MD. | 1 years |
| Thomas Hazel | M | - | 23 years | |
| Jennie C. Hunter-Cevera | M | 76 |
CASI Pharmaceuticals, Inc. /Old/
CASI Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology CASI Pharmaceuticals, Inc. is a biopharmaceutical company, which is focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs. The company develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong, and Macau. Its products include Zevalin, Evomela, and Marqibo. The company was founded in 1991 and is headquartered in Rockville, MD. | - |
| Gerald J. Vardzel | M | 58 |
Helomics Corp.
Helomics Corp. Medical/Nursing ServicesHealth Services Helomics Corp. provides cancer care development and treatment consulting services. Its products include chemoFx, biospeciFx, geneFx colon and geneFx lung. It also offers research and development services. The company was founded in 1995 and is headquartered in Pittsburgh, PA. | 3 years |
| Lee S. Rosen | M | 70 |
New Generation Biofuels Holdings, Inc.
New Generation Biofuels Holdings, Inc. Chemicals: SpecialtyProcess Industries New Generation Biofuels Holdings, Inc. is a clean energy company which deploys novel technologies to produce cleaner, renewable biofuels. The company offers its biofuels for use in diesel fuel applications, including power generation, commercial and industrial heating, and marine transportation. It produces the biofuels using a blending technology. The firm operates through its wholly owned subsidiary, New Generation Biofuels, Inc., which holds an exclusive license for North America, Central America and the Caribbean to commercialize proprietary emulsion technology. The company was founded in February 2006 and is headquartered in Columbia, MD. | 7 years |
| David Mazzo | M | 67 | 2 years | |
| Margot Mongold | F | - |
CASI Pharmaceuticals, Inc. /Old/
CASI Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology CASI Pharmaceuticals, Inc. is a biopharmaceutical company, which is focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs. The company develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong, and Macau. Its products include Zevalin, Evomela, and Marqibo. The company was founded in 1991 and is headquartered in Rockville, MD. | 4 years |
| Amy Finan | F | - |
CASI Pharmaceuticals, Inc. /Old/
CASI Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology CASI Pharmaceuticals, Inc. is a biopharmaceutical company, which is focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs. The company develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong, and Macau. Its products include Zevalin, Evomela, and Marqibo. The company was founded in 1991 and is headquartered in Rockville, MD. | 3 years |
| Carl O. Bauer | M | - |
New Generation Biofuels Holdings, Inc.
New Generation Biofuels Holdings, Inc. Chemicals: SpecialtyProcess Industries New Generation Biofuels Holdings, Inc. is a clean energy company which deploys novel technologies to produce cleaner, renewable biofuels. The company offers its biofuels for use in diesel fuel applications, including power generation, commercial and industrial heating, and marine transportation. It produces the biofuels using a blending technology. The firm operates through its wholly owned subsidiary, New Generation Biofuels, Inc., which holds an exclusive license for North America, Central America and the Caribbean to commercialize proprietary emulsion technology. The company was founded in February 2006 and is headquartered in Columbia, MD. | - |
| Kathy R. Wehmeir-Davis | F | 69 |
CASI Pharmaceuticals, Inc. /Old/
CASI Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology CASI Pharmaceuticals, Inc. is a biopharmaceutical company, which is focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs. The company develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong, and Macau. Its products include Zevalin, Evomela, and Marqibo. The company was founded in 1991 and is headquartered in Rockville, MD. | 8 years |
| Mark Bray | M | 58 |
CASI Pharmaceuticals, Inc. /Old/
CASI Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology CASI Pharmaceuticals, Inc. is a biopharmaceutical company, which is focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs. The company develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong, and Macau. Its products include Zevalin, Evomela, and Marqibo. The company was founded in 1991 and is headquartered in Rockville, MD. | - |
| Carolyn F. Sidor | M | 77 |
CASI Pharmaceuticals, Inc. /Old/
CASI Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology CASI Pharmaceuticals, Inc. is a biopharmaceutical company, which is focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs. The company develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong, and Macau. Its products include Zevalin, Evomela, and Marqibo. The company was founded in 1991 and is headquartered in Rockville, MD. | 11 years |
| Marc G. Corrado | M | - |
CASI Pharmaceuticals, Inc. /Old/
CASI Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology CASI Pharmaceuticals, Inc. is a biopharmaceutical company, which is focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs. The company develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong, and Macau. Its products include Zevalin, Evomela, and Marqibo. The company was founded in 1991 and is headquartered in Rockville, MD. | - |
| Ronald E. Cape | M | 91 |
CASI Pharmaceuticals, Inc. /Old/
CASI Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology CASI Pharmaceuticals, Inc. is a biopharmaceutical company, which is focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs. The company develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong, and Macau. Its products include Zevalin, Evomela, and Marqibo. The company was founded in 1991 and is headquartered in Rockville, MD. | 5 years |
| George Ellis | M | 75 |
Sterling Software, Inc.
 Sterling Software, Inc. Packaged SoftwareTechnology Services Sterling Software, Inc. is used to designs, develops, markets, licenses and supports standardized computer software products. The company was headquartered in Dallas, TX. | 11 years |
| Stanley Lapidus | M | 75 |
Helomics Corp.
Helomics Corp. Medical/Nursing ServicesHealth Services Helomics Corp. provides cancer care development and treatment consulting services. Its products include chemoFx, biospeciFx, geneFx colon and geneFx lung. It also offers research and development services. The company was founded in 1995 and is headquartered in Pittsburgh, PA. | - |
| Peter Knight | M | 73 |
CASI Pharmaceuticals, Inc. /Old/
CASI Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology CASI Pharmaceuticals, Inc. is a biopharmaceutical company, which is focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs. The company develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong, and Macau. Its products include Zevalin, Evomela, and Marqibo. The company was founded in 1991 and is headquartered in Rockville, MD. | 10 years |
| Michael Tarnow | M | 79 |
CASI Pharmaceuticals, Inc. /Old/
CASI Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology CASI Pharmaceuticals, Inc. is a biopharmaceutical company, which is focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs. The company develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong, and Macau. Its products include Zevalin, Evomela, and Marqibo. The company was founded in 1991 and is headquartered in Rockville, MD. | 9 years |
| Thomas H. Bliss | M | - |
CASI Pharmaceuticals, Inc. /Old/
CASI Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology CASI Pharmaceuticals, Inc. is a biopharmaceutical company, which is focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs. The company develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong, and Macau. Its products include Zevalin, Evomela, and Marqibo. The company was founded in 1991 and is headquartered in Rockville, MD. | - |
| Kenneth Walter Bair | M | 76 |
CASI Pharmaceuticals, Inc. /Old/
CASI Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology CASI Pharmaceuticals, Inc. is a biopharmaceutical company, which is focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs. The company develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong, and Macau. Its products include Zevalin, Evomela, and Marqibo. The company was founded in 1991 and is headquartered in Rockville, MD. | 1 years |
| David Gibson | M | - |
Helomics Corp.
Helomics Corp. Medical/Nursing ServicesHealth Services Helomics Corp. provides cancer care development and treatment consulting services. Its products include chemoFx, biospeciFx, geneFx colon and geneFx lung. It also offers research and development services. The company was founded in 1995 and is headquartered in Pittsburgh, PA. | 3 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 42 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Dane Saglio
- Personal Network